1. Home
  2. BW vs LCTX Comparison

BW vs LCTX Comparison

Compare BW & LCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BW
  • LCTX
  • Stock Information
  • Founded
  • BW 1867
  • LCTX 1990
  • Country
  • BW United States
  • LCTX United States
  • Employees
  • BW N/A
  • LCTX N/A
  • Industry
  • BW Building Products
  • LCTX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • BW Industrials
  • LCTX Health Care
  • Exchange
  • BW Nasdaq
  • LCTX Nasdaq
  • Market Cap
  • BW 95.7M
  • LCTX 107.3M
  • IPO Year
  • BW N/A
  • LCTX N/A
  • Fundamental
  • Price
  • BW $1.03
  • LCTX $1.07
  • Analyst Decision
  • BW Buy
  • LCTX Strong Buy
  • Analyst Count
  • BW 2
  • LCTX 5
  • Target Price
  • BW $3.50
  • LCTX $4.20
  • AVG Volume (30 Days)
  • BW 839.8K
  • LCTX 4.3M
  • Earning Date
  • BW 08-07-2025
  • LCTX 08-07-2025
  • Dividend Yield
  • BW N/A
  • LCTX N/A
  • EPS Growth
  • BW N/A
  • LCTX N/A
  • EPS
  • BW N/A
  • LCTX N/A
  • Revenue
  • BW $734,239,000.00
  • LCTX $9,557,000.00
  • Revenue This Year
  • BW $5.81
  • LCTX N/A
  • Revenue Next Year
  • BW $9.24
  • LCTX $232.66
  • P/E Ratio
  • BW N/A
  • LCTX N/A
  • Revenue Growth
  • BW 12.90
  • LCTX 19.42
  • 52 Week Low
  • BW $0.22
  • LCTX $0.37
  • 52 Week High
  • BW $2.99
  • LCTX $1.15
  • Technical
  • Relative Strength Index (RSI)
  • BW 54.12
  • LCTX 65.71
  • Support Level
  • BW $0.99
  • LCTX $0.97
  • Resistance Level
  • BW $1.10
  • LCTX $1.09
  • Average True Range (ATR)
  • BW 0.07
  • LCTX 0.11
  • MACD
  • BW -0.01
  • LCTX -0.00
  • Stochastic Oscillator
  • BW 58.18
  • LCTX 73.30

About BW Babcock & Wilcox Enterprises Inc.

Babcock & Wilcox Enterprises Inc is a power generation equipment supplier and servicing company that operates in three segments: B&W Renewable, B&W Environmental, and B&W Thermal. B&W Thermal, focuses on steam generation products and solutions for plants in the power generation, oil, and gas, and industrial sectors, generates the majority of the company's revenue. B&W Renewable focuses on sustainable power and heat generation while B&W Environmental focuses on emissions control. The company's customer base spans the industrial, electrical utility, and municipal industries located predominantly in the United States, Canada, Denmark, the United Kingdom, and other regions. Business in the U.S. contributes the vast majority of its revenue.

About LCTX Lineage Cell Therapeutics Inc.

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline is based on two platform technologies including cell replacement and cell/drug delivery. Lineage Cell's product candidate is OpRegen, a retinal pigment epithelium transplant therapy for the treatment of dry age-related macular degeneration, OPC1, an oligodendrocyte progenitor cell therapy for acute spinal cord injuries, and VAC2, allogeneic cancer immunotherapy of antigen-presenting dendritic cells for non-small cell lung cancer, ANP1, an allogeneic auditory neuron progenitor cells transplant for hearing loss, and PNC1, an allogeneic photoreceptor cell transplant for vision loss.

Share on Social Networks: